Skip to main content
PMC home page
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 2000 Jan;9(1):29–36. doi: 10.1110/ps.9.1.29

The crystal structures of human alpha-thrombin complexed with active site-directed diamino benzo[b]thiophene derivatives: a binding mode for a structurally novel class of inhibitors.

N Y Chirgadze 1, D J Sall 1, S L Briggs 1, D K Clawson 1, M Zhang 1, G F Smith 1, R W Schevitz 1
PMCID: PMC2144429  PMID: 10739244

Abstract

The crystal structures of four active site-directed thrombin inhibitors, 1-4, in a complex with human alpha-thrombin have been determined and refined at up to 2.0 A resolution using X-ray crystallography. These compounds belong to a structurally novel family of inhibitors based on a 2,3-disubstituted benzo[b]thiophene structure. Compared to traditional active-site directed inhibitors, the X-ray crystal structures of these complexes reveal a novel binding mode. Unexpectedly, the lipophilic benzo[b]thiophene nucleus of the inhibitor appears to bind in the S1 specificity pocket. At the same time, the basic amine of the C-3 side chain of the inhibitor interacts with the mostly hydrophobic proximal, S2, and distal, S3, binding sites. The second, basic amine side chain at C-2 was found to point away from the active site, occupying a location between the S1 and S1' sites. Together, the aromatic rings of the C-2 and C-3 side chains sandwich the indole ring of Trp60D contained in the thrombin S2 insertion loop defined by the sequence "Tyr-Pro-Pro-Trp." [The thrombin residue numbering used in this study is equivalent to that reported for chymotrypsinogen (Hartley BS, Shotton DM, 1971, The enzymes, vol. 3. New York: Academic Press. pp 323-373).] In contrast to the binding mode of more classical thrombin inhibitors (D-Phe-Pro-Arg-H, NAPAP, Argatroban), this novel class of benzo[b]thiophene derivatives does not engage in hydrogen bond formation with Gly216 of the thrombin active site. A detailed analysis of the three-dimensional structures not only provides a clearer understanding of the interaction of these agents with thrombin, but forms a foundation for rational structure-based drug design. The use of the data from this study has led to the design of derivatives that are up to 2,900-fold more potent than the screening hit 1.

Full Text

The Full Text of this article is available as a PDF (2.6 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banner D. W., Hadváry P. Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors. J Biol Chem. 1991 Oct 25;266(30):20085–20093. [PubMed] [Google Scholar]
  2. Bode W., Mayr I., Baumann U., Huber R., Stone S. R., Hofsteenge J. The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J. 1989 Nov;8(11):3467–3475. doi: 10.1002/j.1460-2075.1989.tb08511.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bode W., Turk D., Karshikov A. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships. Protein Sci. 1992 Apr;1(4):426–471. doi: 10.1002/pro.5560010402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chirgadze N. Y., Sall D. J., Klimkowski V. J., Clawson D. K., Briggs S. L., Hermann R., Smith G. F., Gifford-Moore D. S., Wery J. P. The crystal structure of human alpha-thrombin complexed with LY178550, a nonpeptidyl, active site-directed inhibitor. Protein Sci. 1997 Jul;6(7):1412–1417. doi: 10.1002/pro.5560060705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dougherty D. A. Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp. Science. 1996 Jan 12;271(5246):163–168. doi: 10.1126/science.271.5246.163. [DOI] [PubMed] [Google Scholar]
  6. Iwanowicz E. J., Lau W. F., Lin J., Roberts D. G., Seiler S. M. Retro-binding tripeptide thrombin active-site inhibitors: discovery, synthesis, and molecular modeling. J Med Chem. 1994 Jul 8;37(14):2122–2124. doi: 10.1021/jm00040a001. [DOI] [PubMed] [Google Scholar]
  7. Menear K. Progress towards the discovery of orally active thrombin inhibitors. Curr Med Chem. 1998 Dec;5(6):457–468. [PubMed] [Google Scholar]
  8. Sall D. J., Bastian J. A., Briggs S. L., Buben J. A., Chirgadze N. Y., Clawson D. K., Denney M. L., Giera D. D., Gifford-Moore D. S., Harper R. W. Dibasic benzo[b]thiophene derivatives as a novel class of active site-directed thrombin inhibitors. 1. Determination of the serine protease selectivity, structure-activity relationships, and binding orientation. J Med Chem. 1997 Oct 24;40(22):3489–3493. doi: 10.1021/jm9704107. [DOI] [PubMed] [Google Scholar]
  9. Sall D. J., Briggs S. L., Chirgadze N. Y., Clawson D. K., Gifford-Moore D. S., Klimkowski V. J., McCowan J. R., Smith G. F., Wikel J. H. Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. 2. Exploring interactions at the proximal (S2) binding site. Bioorg Med Chem Lett. 1998 Sep 22;8(18):2527–2532. doi: 10.1016/s0960-894x(98)00447-8. [DOI] [PubMed] [Google Scholar]
  10. Sanderson P. E., Naylor-Olsen A. M. Thrombin inhibitor design. Curr Med Chem. 1998 Aug;5(4):289–304. [PubMed] [Google Scholar]
  11. Skrzypczak-Jankun E., Carperos V. E., Ravichandran K. G., Tulinsky A., Westbrook M., Maraganore J. M. Structure of the hirugen and hirulog 1 complexes of alpha-thrombin. J Mol Biol. 1991 Oct 20;221(4):1379–1393. [PubMed] [Google Scholar]
  12. Smith G. F., Shuman R. T., Craft T. J., Gifford D. S., Kurz K. D., Jones N. D., Chirgadze N., Hermann R. B., Coffman W. J., Sandusky G. E. A family of arginal thrombin inhibitors related to efegatran. Semin Thromb Hemost. 1996;22(2):173–183. doi: 10.1055/s-2007-999006. [DOI] [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES